The Timed Up and Go Test in Patients with Haemophilia: Assessing Reliability, Validity, and Predictive Variables [0.03%]
血友病患者进行 timed up and go 测试：评估其可靠性、有效性和预测变量
F Tomschi,M Brühl,A Schmidt et al.
F Tomschi et al.
The Timed Up and Go (TUG) test is frequently used to assess patients' functional mobility. However, its psychometric characteristics in patients with haemophilia (PwH) are unknown. This study's primary aim was to determine the validity, rel...
Jens Müller,Martin Büchsel,Olga Oleshko et al.
Jens Müller et al.
Emicizumab is a bispecific monoclonal antibody that mimics the cofactor function of activated factor VIII (FVIIIa). It is approved for routine prophylaxis in patients with severe or moderate congenital hemophilia A (HA), both with and witho...
Erratum: "Diagnosis of Inherited Platelet Disorders": Update of the Interdisciplinary S2k-Guideline [*] of the Permanent Pediatric Commission of the Society of Thrombosis and Haemostasis Research (GTH e.V.) [0.03%]
《更正：“遗传性血小板疾病诊断”：德国血栓与止血研究学会儿科委员会S2K指南更新》
Jennifer Gebetsberger,Ralf Knöfler,Werner Streif;ThromKidplus study group#;and mandated experts$ from other participating professional societies
Jennifer Gebetsberger
Published Erratum
Hamostaseologie. 2025 Aug;45(4):e1. DOI:10.1055/s-0045-1811974 2025
Performance Evaluation of Different FIX Activity Assays for Determining Nonacog Beta Pegol (N9-GP, Refixia®) Activity Using Reagent-/Platform-Specific Conversion Factors [0.03%]
基于特定检测试剂盒/平台的转换因子评价不同FIX激活实验测定非重组凝血因子IX（N9-GP，Refixia ®）活性的方法学比对试验性能
Christian Irsara,Andrea Griesmacher,Bernhard Strasser et al.
Christian Irsara et al.
Nonacog beta pegol (N9-GP) is a glycoPEGylated FIX replacement product with extended half-life for treatment of haemophilia B patients. Monitoring of N9-GP with clotting-based one-stage FIX assays is complicated by high variations, mainly d...
Stand GOÄ-Novelle, News zur ePA (elektronische Patientenakte), Ambulante Gentherapie für die Hämophilie B [0.03%]
GOÄ-Novelle站起吧，ePA新闻（电子病历），血友病B的门诊基因治疗
Jürgen Koscielny,Christoph Sucker
Jürgen Koscielny
Association Between Major Bleeding and In-Hospital Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in Acute Coronary Syndromes [0.03%]
急性冠脉综合征患者行经皮冠状动脉介入治疗后大出血与住院期间主要心血管事件的关系
Özkan Bekler,Alparslan Kurtul,Emirhan Hancıoğlu et al.
Özkan Bekler et al.
Major bleeding (MB) is a serious complication in patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI). Although its association with long-term adverse outcomes is well documented, the impact of in...
"Diagnosis of Inherited Platelet Disorders": Update of the Interdisciplinary S2k-Guideline [] of the Permanent Pediatric Commission of the Society of Thrombosis and Haemostasis Research (GTH e.V.) [0.03%]
《遗传性血小板病的诊断》：更新儿科永久委员会关于血栓形成及止血研究学会(S2K指南)的跨学科指南[])
Jennifer Gebetsberger,Ralf Knöfler,Werner Streif;ThromKidplus study group#;and mandated experts$ from other participating professional societies
Jennifer Gebetsberger
Inherited platelet disorders (IPD) are a heterogeneous group of diseases causing bleeding, which are often challenging to diagnose. To improve the diagnostic process for these disorders, the ThromKidplus study group of the Permanent Pediatr...